Unibest
← Back to patent-cliff list

CAS 1372611-82-9

Methyl exo,exo-3-(4-iodophenyl)spiro[bicyclo[3.2.1]octane-8,1'-azetidinium]-2-carboxylate

Codes: 18F-FP-CIT-007

Application context (from source-drug indications)

Parkinson's disease18F-FP-CIT

Source drugs (routes using this intermediate)

DrugTierExpiry
18F-FP-CITTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

18F-FP-CITOptimised routesteps: 2total yield: /
Methyl exo,exo-3-(4-iodophenyl)-8-(3-[[(4-methylphenyl)sulfonyl]oxy]propyl)-8-azabicyclo[3.2.1]octane-2-carboxylate→Methyl exo,exo-3-(4-iodophenyl)spiro[bicyclo[3.2.1]octane-8,1'-azetidinium]-2-carboxylate

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.